Disposition of smoked cannabis with high δ9-tetrahydrocannabinol content: A kinetic model

Toxicology and Applied Pharmacology

Volumn 246, Issue 3, 2010, Pages 148-153

  Hunault, Claudine C ^a   van Eijkeren, Jan C H ^a   Mensinga, Tjeert T ^a,b   de Vries, Irma ^a   Leenders, Marianne E C ^a,c   Meulenbelt, Jan ^a,c,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Clinic for Treatment of Drug Addiction in Northern   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cannabis; Pharmacokinetics; THC; Two compartment model

Indexed keywords

CANNABIS; DRONABINOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANNABIS SMOKING; DOSE RESPONSE; HUMAN; KINETICS; MALE; MAXIMUM PLASMA CONCENTRATION; PLASMA HALF LIFE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADOLESCENT; ADULT; AREA UNDER CURVE; CANNABIS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRONABINOL; HALF-LIFE; HUMANS; KINETICS; MALE; SMOKE; SMOKING; YOUNG ADULT;

CANNABIS; NICOTIANA TABACUM;

EID: 77956874708     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.04.019     Document Type: Article

References (26)

1. Barnett G., Chiang C.W., Perez-Reyes M., Owens S.M. Kinetic study of smoking marijuana. J. Pharmacokinet. Biopharm. 1982, 76:204-212.
2. Barnett G., Licko V., Thompson T. Behavioral pharmacokinetics of marijuana. Psychopharmacology 1985, 76:204-212.
3. Chiang C.N., Barnett G. Marijuana effect and delta 9-tetrahydrocannabinol plasma level. Clin. Pharmacol. Ther. 1984, 76:204-212.
4. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 2003, 76:204-212.
5. Harder S. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marihuana. Int. J. Clin. Pharmacol. Ther. 1997, 76:204-212.
6. Hollister L., Gillespie H., Ohlsson A., Lindgren J.E., Wahlén A., Agurell S. Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?. J. Clin. Pharmacol. 1981, 76:204-212.
7. Huestis M., Nahas G.G., Sutin K.M., Harvey D., Agurell S. Pharmacokinetics of THC in inhaled and oral preparations. Marihuana and Medicine 1999, 105-116. Humana Press Inc, Totowa, NJ, USA.
8. Huestis M.A., Barnes A., Smith M.L. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations. Clin. Chem. 2005, 76:204-212.
9. Huestis M.A., Henningfield J.E., Cone E.J. Blood cannabinoids.I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J. Anal. Toxicol. 1992, 76:204-212.
10. Huestis M.A., Sampson A.H., Holicky B.J., Henningfield J.E., Cone E.J. Characterization of the absorption phase of marijuana smoking. Clin. Pharmacol. Ther. 1992, 76:204-212.
11. Hunault C.C., Mensinga T.T., de Vries I., Kelholt-Dijkman H.H., Hoek J., Kruidenier M., Leenders M.E., Meulenbelt J. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69mg THC. Psychopharmacology (Berl). 2008, 76:204-212.
12. Hunt C.A., Jones R.T. Tolerance and disposition of tetrahydrocannabinol in man. J. Pharmacol. Exp. Ther. 1980, 76:204-212.
13. Johansson E.K., Hollister L.E., Halldin M.M. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. NIDA Res. Monogr. 1989, 76:204-212.
14. Lemberger L., Tamarkin N.R., Axelrod J., Kopin I.J. Delta 9-tetracannabinol: metabolism and disposition in long-term marijuana smokers. Science 1971, 76:204-212.
15. Leuschner J.T.A., Harvey D.J., Bullingham R.E.S., Paton W.D.M. Pharmacokinetics of delta 9-tetracannabinol in rabbits following single or multiple intravenous doses. Drug Metab. Dispos. 1986, 76:204-212.
16. Lindgren J.E., Ohlsson A., Agurell S., Hollister L., Gillespie H. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology 1981, 76:204-212.
17. Ménétrey A., Augsburger M., Fayrat B., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mangin P., Giroud C. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20mg dronabinol or of a cannabis decoction made with 20 or 60mg Delta9-THC. J. Anal. Toxicol. 2005, 29:327-338.
18. Nahas G.G. Marijuana: toxicity and tolerance. Medical aspects of drug abuse 1975, 16-36. Harper & Row, Baltimore, USA. R.W. Richter (Ed.).
19. Ohlsson A., Lindgren J.E., Wahlén A., Agurell S., Hollister L., Gillespie H.K. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Biomed. Mass Spectrom. 1982, 76:204-212.
20. Perez-Reyes M. Comparison of effects of marihuana cigarettes of three different potencies. Clin. Pharmacol. Ther. 1982, 76:204-212.
21. Ramaekers J.G., Moeller M.R., van Ruitenbeek P., Theunissen E.L., Schneider E., Kauert G. Cognition and motor control as a function of delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend. 2006, 76:204-212.
22. Ramaekers J., Kauert G., Theunissen E., Toennes S., Moeller M. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J. Psychopharmacol. 2008, 76:204-212.
23. Strougo A., Zuurman L., Roy C., Pinquier J.L., van Gerven J.M., Cohen A.F., Schoemaker R.C. Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate - insight into its mechanisms of action and a tool for clinical research and development of cannabinoids. J. Psychopharmacol. 2008, 76:204-212.
24. TrimbosInstitute, 2008. Nationale Drug Monitor, Jaarbericht 2007.
25. United Nations Office on Drugs and Crime, 2006. World drug report. Volume 1 (Analysis). United Nation Publication Sales no.E.06.XI.10.
26. Wall M.E., Sadler B.M., Brine D., Taylor H., Perez-Reyes M. Metabolism, disposition, and kinetics of delta 9-tetrahydrocannabinol in men and women. Clin. Pharmacol. Ther. 1983, 76:204-212.